english.prescrire.org > Spotlight > 100 most recent > Revision of European pharmaceutical legislation: a disappointing vote in the Parliament

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Revision of European pharmaceutical legislation: a disappointing vote in the Parliament

 Advancing Healthcare Policy   In April 2024, MEPs voted on the European Commission's proposals for the revision of European pharmaceutical legislation. Overall, despite a number of welcome advances, MEPs failed to take advantage of the opportunity to strengthen drug evaluation and patient safety.
Full article (2 pages) available for download (free)

 ©Prescrire 1 November 2024

Source: "Revision of European pharmaceutical legislation: a disappointing vote in the Parliament" Prescrire Int 2024; 33 (264): 278-279. Free.

Enjoy full access to Prescrire International, and support independent information

 

Share
Share on  Facebook Share on  Twitter
 
See also:

"European pharmaceutical
legislation: too many opportunities
missed by MEPs"
Prescrire Int 2024;
33 (264): 255.
Free

"Revision of European
pharmaceutical legislation"
Prescrire Int 2024;